Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -86.77% | -6.31% | -42.65% | -28.52% | -1.46% |
| Total Receivables | -- | -- | -3.82% | 1.01% | 0.61% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -24.49% | -9.68% | -21.09% | 95.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 0.00% | 0.00% | -- | -- |
| Total Current Assets | -80.28% | -18.82% | -38.04% | -25.94% | 0.29% |
|
|
|||||
| Total Current Assets | -80.28% | -18.82% | -38.04% | -25.94% | 0.29% |
| Net Property, Plant & Equipment | -92.03% | -4.17% | -7.10% | -7.19% | -6.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -80.74% | -18.27% | -37.30% | -25.58% | 0.14% |
|
|
|||||
| Total Accounts Payable | -85.34% | 34.88% | -8.91% | -4.52% | -2.55% |
| Total Accrued Expenses | -97.91% | -1.01% | -1.67% | -1.52% | -0.12% |
| Short-term Debt | -79.74% | 52.30% | -65.03% | -53.54% | 50.56% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 20.34% | 0.34% | 25.64% | 34.48% |
| Total Other Current Liabilities | -- | 20.34% | 0.34% | 25.64% | 34.48% |
| Total Current Liabilities | -93.07% | 18.23% | -17.19% | -18.74% | 20.33% |
|
|
|||||
| Total Current Liabilities | -93.07% | 18.23% | -17.19% | -18.74% | 20.33% |
| Long-Term Debt | -- | 7.30% | -3.03% | 27.82% | 1.37% |
| Short-term Debt | -79.74% | 52.30% | -65.03% | -53.54% | 50.56% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -95.03% | 457.43% |
| Total Liabilities | -94.19% | 16.30% | -15.87% | -26.14% | 33.95% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.28% | 0.00% | 0.68% | 0.00% |
| Retained Earnings | 11.04% | -1.23% | -0.94% | -0.34% | -2.15% |
| Treasury Stock & Other | -- | 0.00% | -8.79% | 10.03% | 0.00% |
| Total Common Equity | -106.07% | -38.32% | -45.74% | 48.42% | -39.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -106.07% | -38.32% | -45.74% | 48.42% | -39.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -3.83% | 25.39% | -2.19% | -2.25% |
| Total Equity | 98.08% | -32.49% | -0.16% | 26.55% | -78.42% |
|
|
|||||